Practical use and prescription of ocular medications in children and infants
- 24 February 2021
- journal article
- review article
- Published by Informa UK Limited in Clinical and Experimental Optometry
- Vol. 104 (3), 385-395
- https://doi.org/10.1080/08164622.2021.1877533
Abstract
Optometrists in Australia employ ophthalmic medicines in their paediatric practice to assist clinical diagnosis and to treat ocular conditions. Prior to employing ocular medicines or initiating treatment, it is important to consider the risks versus benefits of ophthalmic medicines and determine the minimum dose required to safely achieve a diagnostic or therapeutic benefit. Instilling drops in infants and young children may require techniques that do not depend on full cooperation, particularly to maintain appropriate dosing and limit the rate of elimination from the eye. Diagnostic cycloplegic agents are highly recommended for the accurate determination of refractive error in infants and young children. Topical atropine is commonly prescribed in paediatric optometry practice in highly variable concentrations. 1% atropine eye drops are used for pharmacological penalisation in management of amblyopia, and, increasingly, low concentration (< 0.1%) atropine is used to manage the progression of childhood myopia. Doses of topical ocular medicines to treat inflammation, infection or glaucoma are generally identical to those use in adults; however, there is potential for increased ocular and systemic side effects with certain medications. It is, therefore, timely to present, summarise and comment on the use of ophthalmic diagnostic and therapeutic agents in children and reference where practitioners can look for more detailed information. The perspective is set in the Australian context of a collaborative approach between paediatric optometry and ophthalmology eye care practitioners for delivery of best practice care in infants and young children. Inclusion of the more complex spectrum of paediatric eye disease in a tertiary ophthalmological setting is provided to build practitioner knowledge of treatment regimens their patients may be using, even though management of these conditions lies outside their scope of practice.Keywords
This publication has 42 references indexed in Scilit:
- Clinical and microbiological profile of infectious keratitis in childrenBMC Ophthalmology, 2013
- Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye dropsClinical Ophthalmology, 2013
- Effect of Age on Response to Amblyopia Treatment in ChildrenAmerican Journal of Ophthalmology, 2011
- Treatment of severe amblyopia with weekend atropine: Results from 2 randomized clinical trialsJournal of American Association for Pediatric Ophthalmology and Strabismus, 2009
- Patching vs Atropine to Treat Amblyopia in Children Aged 7 to 12 YearsAmerican Journal of Ophthalmology, 2008
- Herpes Zoster OphthalmicusNatural History, Risk Factors, Clinical Presentation, and MorbidityOphthalmology, 2008
- Why atropine drops should be used in Down syndromeBritish Journal of Ophthalmology, 2008
- Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trialThe Lancet, 2005
- Principles of Drug Prescribing in Infants and ChildrenDrugs, 1993
- A Prospective, Masked Clinical Trial of Trifluridine, Dexamethasone, and Artificial Tears in the Treatment of Epidemic KeratoconjunctivitisCornea, 1993